| Dr Peter Muz, MD | |
|
54 Baker Avenue Ext 305, Concord, MA 01742-2143 | |
| (978) 371-7010 | |
| Not Available |
| Full Name | Dr Peter Muz |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 34 Years |
| Location | 54 Baker Avenue Ext 305, Concord, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124006127 | NPI | - | NPPES |
| 3173593 | Medicaid | MA | |
| 0814600 | Other | MA | AETNA |
| M18327 | Other | MA | BLUE CROSS/SHIELD |
| 542112330 | Other | MA | TRICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 75553 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emerson Hospital - | W concord, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adult And Pediatric Dermatology Pc | 7012988306 | 31 |
News Archive
ProBuild Company LLC, one of the nation's largest suppliers of building materials to professional contractors, continued its commitment to further cancer and diabetes research by hosting its 2010 Charity Golf Tournament at The Omni Interlocken Resort and Hotel in Broomfield, Colo. ProBuild and its supply partners from across the Rocky Mountain Region together raised more than $275,000 for City of Hope, one of the nation's leading research and treatment centers for cancer, diabetes and other life-threatening diseases.
The Society of Interventional Radiology has a long-term commitment to radiation safety, taking a leading role in measuring and assessing radiation dosage; developing educational programs on radiation safety, radiation protection and reduction of skin dosage; and promoting the safety of patients and health care professionals.
In work supported by The ALS Association, researchers have shown that increasing the clearance of misfolded protein from neurons improves their survival. The study was published today in the journal Nature Chemical Biology.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
Super Bowl-winning lineman turned orthopaedic surgeon Mark Adickes, M.D., is moderating a free public forum to help parents, athletes and trainers spot the warning signs of concussion.
› Verified 4 days ago
| Entity Name | Adult & Pediatric Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285614834 PECOS PAC ID: 7012988306 Enrollment ID: O20040802000790 |
News Archive
ProBuild Company LLC, one of the nation's largest suppliers of building materials to professional contractors, continued its commitment to further cancer and diabetes research by hosting its 2010 Charity Golf Tournament at The Omni Interlocken Resort and Hotel in Broomfield, Colo. ProBuild and its supply partners from across the Rocky Mountain Region together raised more than $275,000 for City of Hope, one of the nation's leading research and treatment centers for cancer, diabetes and other life-threatening diseases.
The Society of Interventional Radiology has a long-term commitment to radiation safety, taking a leading role in measuring and assessing radiation dosage; developing educational programs on radiation safety, radiation protection and reduction of skin dosage; and promoting the safety of patients and health care professionals.
In work supported by The ALS Association, researchers have shown that increasing the clearance of misfolded protein from neurons improves their survival. The study was published today in the journal Nature Chemical Biology.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
Super Bowl-winning lineman turned orthopaedic surgeon Mark Adickes, M.D., is moderating a free public forum to help parents, athletes and trainers spot the warning signs of concussion.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Muz, MD 526 Main St, Acton, MA 01720-3301 Ph: (978) 849-7505 | Dr Peter Muz, MD 54 Baker Avenue Ext 305, Concord, MA 01742-2143 Ph: (978) 371-7010 |
News Archive
ProBuild Company LLC, one of the nation's largest suppliers of building materials to professional contractors, continued its commitment to further cancer and diabetes research by hosting its 2010 Charity Golf Tournament at The Omni Interlocken Resort and Hotel in Broomfield, Colo. ProBuild and its supply partners from across the Rocky Mountain Region together raised more than $275,000 for City of Hope, one of the nation's leading research and treatment centers for cancer, diabetes and other life-threatening diseases.
The Society of Interventional Radiology has a long-term commitment to radiation safety, taking a leading role in measuring and assessing radiation dosage; developing educational programs on radiation safety, radiation protection and reduction of skin dosage; and promoting the safety of patients and health care professionals.
In work supported by The ALS Association, researchers have shown that increasing the clearance of misfolded protein from neurons improves their survival. The study was published today in the journal Nature Chemical Biology.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
Super Bowl-winning lineman turned orthopaedic surgeon Mark Adickes, M.D., is moderating a free public forum to help parents, athletes and trainers spot the warning signs of concussion.
› Verified 4 days ago
Shelley Yang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext Ste 305&306, Concord, MA 01742 Phone: 978-371-7010 Fax: 978-371-0522 | |
Dr. Terry P Hadley, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 290 Baker Ave, Concord, MA 01742 Phone: 978-369-9023 | |
Brandon Rowe, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext Ste 305&306, Concord, MA 01742 Phone: 351-300-0110 | |
Matthew T Zipoli, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 290 Baker Ave, Concord, MA 01742 Phone: 978-369-9023 Fax: 978-371-9675 | |
David E Geist, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext Ste 305, Concord, MA 01742 Phone: 978-371-7010 | |
Caroline L Levine, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 290 Baker Ave, Concord, MA 01742 Phone: 978-369-9023 Fax: 978-371-9675 |